Literature DB >> 32744364

Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence.

Petra Lázničková1,2, Tomáš Kepák1,3, Marcela Hortová-Kohoutková1, Luděk Horváth1, Kateřina Sheardová1,4, Rafal Marciniak1, Carmine Vacca5, Michaela Šiklová6, Teresa Zelante5, Lenka Rossmeislová6, Zdenka Křenová3, Jaroslav Štěrba1,3, Kamila Bendíčková1, Jan Frič1,7.   

Abstract

Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8+ T cell compartment and elevated plasma TNF-α but in later follow-up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors.
© 2020 The Authors. European Journal of Immunology published by Wiley-VCH GmbH.

Entities:  

Keywords:  adverse late effects; childhood; immune recovery; immunosenescence; neuroblastoma

Mesh：

Substances：

Year:  2020        PMID： 32744364      PMCID： PMC7754117          DOI： 10.1002/eji.202048541

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


  9 in total

Review 1.  Inflammatory networks during cellular senescence: causes and consequences.

Authors:  Adam Freund; Arturo V Orjalo; Pierre-Yves Desprez; Judith Campisi
Journal:  Trends Mol Med       Date:  2010-05-03       Impact factor: 11.951

Review 2.  Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era.

Authors:  Rachel Phelan; Hesham Eissa; Kerri Becktell; Neel Bhatt; Matthew Kudek; Brandon Nuechterlein; Lauren Pommert; Ryuma Tanaka; K Scott Baker
Journal:  Curr Oncol Rep       Date:  2019-11-25       Impact factor: 5.075

Review 3.  Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans.

Authors:  Claudio Franceschi; Miriam Capri; Daniela Monti; Sergio Giunta; Fabiola Olivieri; Federica Sevini; Maria Panagiota Panourgia; Laura Invidia; Laura Celani; Maria Scurti; Elisa Cevenini; Gastone C Castellani; Stefano Salvioli
Journal:  Mech Ageing Dev       Date:  2006-11-20       Impact factor: 5.432

4.  Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.

Authors:  Marco Demaria; Monique N O'Leary; Jianhui Chang; Lijian Shao; Su Liu; Fatouma Alimirah; Kristin Koenig; Catherine Le; Natalia Mitin; Allison M Deal; Shani Alston; Emmeline C Academia; Sumner Kilmarx; Alexis Valdovinos; Boshi Wang; Alain de Bruin; Brian K Kennedy; Simon Melov; Daohong Zhou; Norman E Sharpless; Hyman Muss; Judith Campisi
Journal:  Cancer Discov       Date:  2016-12-15       Impact factor: 39.397

5.  Young adult survivors of childhood acute lymphoblastic leukemia show evidence of chronic inflammation and cellular aging.

Authors:  Hany Ariffin; Mohamad Shafiq Azanan; Sayyidatul Syahirah Abd Ghafar; Lixian Oh; Kee Hie Lau; Tharshanadhevasheri Thirunavakarasu; Atiqah Sedan; Kamariah Ibrahim; Adelyne Chan; Tong Foh Chin; Fong Fong Liew; Shareni Jeyamogan; Erda Syerena Rosli; Rashidah Baharudin; Tsiao Yi Yap; Roderick Skinner; Su Han Lum; Pierre Hainaut
Journal:  Cancer       Date:  2017-06-27       Impact factor: 6.860

Review 6.  Senescent cells as a source of inflammatory factors for tumor progression.

Authors:  Albert R Davalos; Jean-Philippe Coppe; Judith Campisi; Pierre-Yves Desprez
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

7.  Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus.

Authors:  Mohamad Shafiq Azanan; Noor Kamila Abdullah; Ling Ling Chua; Su Han Lum; Sayyidatul Syahirah Abdul Ghafar; Adeeba Kamarulzaman; Shahrul Kamaruzzaman; Sharon R Lewin; Yin Ling Woo; Hany Ariffin; Reena Rajasuriar
Journal:  Eur J Immunol       Date:  2016-05-19       Impact factor: 5.532

Review 8.  The senescence-associated secretory phenotype: the dark side of tumor suppression.

Authors:  Jean-Philippe Coppé; Pierre-Yves Desprez; Ana Krtolica; Judith Campisi
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence.

Authors:  Petra Lázničková; Tomáš Kepák; Marcela Hortová-Kohoutková; Luděk Horváth; Kateřina Sheardová; Rafal Marciniak; Carmine Vacca; Michaela Šiklová; Teresa Zelante; Lenka Rossmeislová; Zdenka Křenová; Jaroslav Štěrba; Kamila Bendíčková; Jan Frič
Journal:  Eur J Immunol       Date:  2020-08-18       Impact factor: 5.532
  9 in total
  2 in total

Review 1.  Immunosenescence in Childhood Cancer Survivors and in Elderly: A Comparison and Implication for Risk Stratification.

Authors:  Petra Lázničková; Kamila Bendíčková; Tomáš Kepák; Jan Frič
Journal:  Front Aging       Date:  2021-07-19

2.  Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence.

Authors:  Petra Lázničková; Tomáš Kepák; Marcela Hortová-Kohoutková; Luděk Horváth; Kateřina Sheardová; Rafal Marciniak; Carmine Vacca; Michaela Šiklová; Teresa Zelante; Lenka Rossmeislová; Zdenka Křenová; Jaroslav Štěrba; Kamila Bendíčková; Jan Frič
Journal:  Eur J Immunol       Date:  2020-08-18       Impact factor: 5.532
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.